HA

Houman Ashrafian

Executive Vice President, Head of Research and Development

Greater London, England

Invests in

Stages:

Sectors:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Work Experience

2023

  • Executive Vice President, Head of Research and Development

    2023

  • Chairman Of The Board

    2016

    Weatherden is a leading early clinical development company with a unique model providing partners with rapid, expert, high-quality drug development solutions. Facilitated by global relationships with external experts in all therapeutic areas, Weatherden’s experience extends to all aspects of translational drug discovery and development.

  • Head of Experimental Therapeutics - Radcliffe Department of Medicine

    2014

  • Honorary Consultant Cardiologist / Co-lead inherited cardiac conditions service

    2011

2020 - 2023

  • Chairman Of The Board

    2020 - 2023

2020 - 2023

  • Director

    2020 - 2023

  • Chairman Of The Board

    2019 - 2023

  • Director

    2018 - 2023

  • Investment Advisor

    2018 - 2023

2016 - 2023

  • Managing Partner

    2018 - 2023

  • Partner

    2017 - 2018

  • Venture Partner

    2016 - 2017